QUMAS also Announces DIA Exhibition Partners
JERSEY CITY, NJ – June 12, 2014 – QUMAS, an Accelrys, Inc. company, today announced that it will be showcasing QUMAS iX, a next-generation compliant collaboration solution for secure content sharing with third party organizations, in booth 2145 at the DIA 2014 50th Annual Meeting being held at the San Diego Convention Center in San Diego, California on June 16-19, 2014.
QUMAS iX is a purpose built solution that provides a managed bridge from your existing document management system to a safe, secure, scalable qualified environment for exchanging controlled regulatory and GxP information with third parties. QUMAS iX can share content from a range of document management systems, ensuring your supply chain and partner network adhere to your standards, processes and expectations.
Users across the Life Sciences ecosystem of partners, including CROs, CMOs, suppliers, vendors and sponsors, can view, search, print and collaborate on shared information by accessing the content through a web browser that directs them to a dedicated cloud-based QUMAS iX environment on Microsoft SharePoint.
The QUMAS booth will also feature a Partner Pavilion providing DIA attendees with an opportunity to meet with a number of recommended QUMAS Partners that offer a range of complimentary solutions and services. The following organizations will be exhibiting at the Partner Pavilion:
- epista IT –provides Microsoft SharePoint services for Life Sciences, including platform qualification, implementation, compliance, and validation.
- NetDimensions – provides an award-winning Learning Management System that has been validated for 21 CFR Part 11 regulatory requirements and has been integrated with the QUMAS Compliance Platform.
- EXTEDO – delivers submission management capabilities that leverage controlled content for multiple submissions to global regulatory authorities.
- Adlib Software – provides key PDF capabilities that eliminate paper while automating document-centric activities, a critical element of compliant Quality Management from QUMAS.
QUMAS, an Accelrys, Inc. company, is the leader in Enterprise Compliance Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Gold Microsoft Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit www.qumas.com.
Accelrys is a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific foundation optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, QA/QC and manufacturing phases of product development. Accelrys offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using Accelrys technology, scientific innovators can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing.
Accelrys solutions are used by more than 2,000 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs approximately 225 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.
UPDATE: On January 30, 2014, Dassault Systèmes, the 3DEXPERIENCE Company and Accelrys, Inc. announced the signing of a definitive merger agreement for Dassault Systèmes to acquire Accelrys. Under the terms and conditions of the merger agreement, Dassault Systèmes made an all-cash tender offer for all of the outstanding shares of Accelrys common stock. The tender offer statement and other documents filed by Dassault Systèmes and Accelrys with the SEC are available for free at the SEC’s website (http://www.sec.gov) and may be obtained at no charge by directing a request by mail to Innisfree M&A Incorporated, 501 Madison Avenue, 20th Floor, New York, New York, 10022 or by calling (888) 750-5834.
The tender offer process was completed on April 29, 2014. Accelrys filed Form 15 (Certification and Notice of Termination of Registration) with the SEC on May 9, meaning Accelrys is no longer publicly traded (and the company’s NASDAQ listing will shortly expire).
Combining with Accelrys will enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systèmes’ formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries.
Accelrys will now become BIOVIA as part of Dassault Systèmes.
All trade names, trademarks, and service marks are rightful property of their respective owners.